It's How Medicine Should Be®


French German Italian Portuguese Russian

Imaging Study to Detect to Amyloid in the Brain of People With Memory Problems

Clinical Trial Title: 
Imaging Study to Detect Amyloid in the Brain of People with Memory Problems
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Raj C. Shah, MD
Clinical Trial Protocol Description: 

The purpose of this study is to test the ability of an experimental PET imaging compound to detect brain amyloid in people with memory problems. Amyloid is a protein associated with Alzheimer’s disease. At Rush University Medical Center, we expect to recruit approximately 10 people.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are 55 years of age or older
  • Have been diagnosed with memory problems, referred to as mild cognitive impairment (MCI)
  • Have a study partner willing to accompany you to study visits and to provide information about you to study staff

You will be excluded from this study if you:

  • Are unwilling or unable to undergo all study procedures (including memory testing, MRI and PET scans)

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Alzheimer’s Disease and Related Dementias
Contact Phone: 
(312) 563-4111
Contact Name: 
Mary Messenger